About
An international showcase of speakers and panellists from industry, academia, FDA/MHRA and legal services
Date: Friday 7 September 2018,
Time: 9am-5pm (followed by networking reception)
Venue: Christ's College, Cambridge
Register: cebil-2018.eventbrite.co.uk
Black-box precision medicine is an exciting new frontier in health care diagnostics, harnessing the power of big data and artificial intelligence to examine newly available troves of health data, including genomic sequences, patient clinical care records, and the results of diagnostic tests.
This one-day symposium aims to tackle some of the challenging issues raised by black-box precision medicine, particularly for legal and regulatory frameworks, including:
- What are the distinguishing features and added benefits of black-box medicine in comparison to traditional personalized medicine?
- What are the legal hurdles to the further development of black-box medicine?
- How does the IVD framework differ for black box medicine in the US and Europe?
- How is the precision medicine industry (academic and commercial) responding to the regulatory and IP challenges?
Confirmed speakers include Dr Alberto Gutierrez (FDA 2009-2017), Prof Glenn Cohen (Harvard), Emeritus Prof Chris Lowe (Cambridge Academy of Therapeutic Sciences), Prof Timo Minssen (Copenhagen), Prof Mateo Aboy (Cambridge), Dr John Liddicoat (Cambridge), Dr Stuart Hogarth (Cambridge), Nicholson Price (Michigan), and Jacob Sherkow (New York)
Open to all interested in law and biomedical research including: *academic and clinical researchers * biotech and pharma industry professionals *independent, in-house and academic lawyers